Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
Acute leukemia, a rare but fatal complication after liver transplantation
Leukemia Research, 07/10/09
Jiang N et al. - The authors' experience suggests that clinicians should adjust the immunosuppressive agents according to the immunosuppressive state of the patient and explore the option of reducing or stopping the medication as long as liver function remains stable. These measures could help reduce the high mortality rate among these patients.
Related Articles
Acute pulmonary failure during remission induction chemotherapy in adults with acute myeloid leukemia or high-risk myelodysplastic syndrome
Cancer, 10/29/09
Relevance Score: 69%
Daunorubicin Versus Mitoxantrone Versus Idarubicin as Induction and Consolidation Chemotherapy for Adults With Acute Myeloid Leukemia: The EORTC and GIMEMA Groups Study AML-10
Journal of Clinical Oncology, 10/23/09
Relevance Score: 68%
Acute myeloid leukemia with mutated NPM1: diagnosis, prognosis and therapeutic perspectives
Current Opinion in Oncology, 10/14/09
Relevance Score: 68%
FLT3 inhibition as a targeted therapy for acute myeloid leukemia
Current Opinion in Oncology, 10/14/09
Relevance Score: 68%
Unrelated Hematopoietic Stem Cell Transplantation for Children with Acute Leukemia: Experience at a Single Institution
Journal of Korean Medical Science, 10/05/09
Relevance Score: 68%
Today in HemeOnc Emergencies...keeping you current
Receive free subspecialty "5-minute updates" via email
The Effect of Intraventricular Administration of Nicardipine on Mean Cerebral Blood Flow Velocity Measured by Transcranial Doppler in the Treatment of Vasospasm Following Aneurysmal Subarachnoid Hemorrhage
Neurocritical Care , 12/16/09
Moderate Hypoglycemia is Associated With Vasospasm, Cerebral Infarction, and 3-Month Disability After Subarachnoid Hemorrhage
Neurocritical Care , 12/16/09
Polo-like kinase inhibitors: an emerging opportunity for cancer therapeutics
Expert Opinion on Investigational Drugs, 12/16/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


